SRPT

Sarepta Therapeutics, Inc. Press Releases

$13.92
*  
0.04
0.29%
Get SRPT Alerts
*Delayed - data as of Dec. 26, 2014  -  Find a broker to begin trading SRPT now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Sarepta Therapeutics to Host Webcast and Conference Call for the Duchenne Muscular Dystrophy Community on December 2, 2014
11/24/2014 4:30:00 PM - Business Wire


Sarepta Therapeutics to Present Company Overview at Upcoming Conferences
11/24/2014 7:00:00 AM - Business Wire


Robbins Arroyo LLP Is Investigating the Officers and Directors of Sarepta Therapeutics, Inc. (SRPT) on Behalf of Shareholders
11/18/2014 3:24:00 PM - PR Newswire


Sarepta Therapeutics Announces First Patient Dosed in Confirmatory Study of Eteplirsen in Ambulant Patients with Duchenne Muscular Dystrophy
11/18/2014 9:15:00 AM - Business Wire


INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Sarepta Therapeutics, Inc. (SRPT) To Contact The Firm
11/14/2014 6:16:00 PM - PR Newswire


Sarepta Therapeutics Announces First Patient Dosed in Study of Eteplirsen in Non-Ambulant Patients with Duchenne Muscular Dystrophy
11/12/2014 5:15:00 PM - Business Wire
▼-10.37 % Price Change since this news event. The Volume Ratio is 0.53.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Sarepta Therapeutics Announces Third Quarter 2014 Financial Results and Recent Corporate Developments
11/6/2014 7:00:00 AM - Business Wire
▼-8.12 % Price Change since this news event. The Volume Ratio is 0.92.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Sarepta Therapeutics to Present Company Overview at Upcoming Conferences
11/4/2014 7:00:00 AM - Business Wire
▼-13.81 % Price Change since this news event. The Volume Ratio is 0.43.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Sarepta Therapeutics to Announce Third Quarter 2014 Financial Results and Corporate Update on November 6, 2014
10/31/2014 3:30:00 PM - Business Wire
▼-14.07 % Price Change since this news event. The Volume Ratio is 0.88.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Sarepta Therapeutics Announces Regulatory Update on Eteplirsen
10/27/2014 7:00:00 AM - Business Wire
▼-40.39 % Price Change since this news event. The Volume Ratio is 18.11.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Sarepta Therapeutics Announces Publication of Ebola and Marburg Phase I Clinical Study Results in Antimicrobial Agents and Chemotherapy
10/16/2014 4:10:00 PM - Business Wire
▼-37.58 % Price Change since this news event. The Volume Ratio is 2.82.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Sarepta Therapeutics Announces Presentations at the 19th International Congress of the World Muscle Society
10/8/2014 8:30:00 AM - Business Wire


Sarepta Therapeutics Announces Favorable Safety Results from Phase I Clinical Study of Influenza Drug Candidate
9/30/2014 7:30:00 AM - Business Wire